Drug Information

Drug General Information
Drug ID
D00ISN
Former ID
DIB015980
Drug Name
MT-1303
Indication Multiple scierosis [ICD9: 340; ICD10:G35] Phase 2 [524345]
Company
Mitsubishi Tanabe Pharma Corp
Target and Pathway
Target(s) Sphingosine 1-phosphate receptor 1 Target Info Modulator [533299]
KEGG Pathway FoxO signaling pathway
Sphingolipid signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway IL4 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
IL2 Signaling Pathway
Pathway Interaction Database Fc-epsilon receptor I signaling in mast cells
S1P3 pathway
S1P1 pathway
Sphingosine 1-phosphate (S1P) pathway
PDGFR-beta signaling pathway
Reactome G alpha (i) signalling events
Lysosphingolipid and LPA receptors
WikiPathways Signal Transduction of S1P Receptor
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 524345ClinicalTrials.gov (NCT01890655) Extension Study of MT-1303. U.S. National Institutes of Health.
Ref 533299Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis. CNS Drugs. 2015 Jul;29(7):565-75.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.